Natriuretic peptide hormone measurement in acute coronary syndrome

Param Maewal, James A de Lemos

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Cardiac ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.

Original languageEnglish (US)
Pages (from-to)365-368
Number of pages4
JournalHeart Failure Reviews
Issue number4
StatePublished - Oct 2003


  • Acute coronary syndromes
  • BNP
  • Natriuretic peptide
  • Risk-stratification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Natriuretic peptide hormone measurement in acute coronary syndrome'. Together they form a unique fingerprint.

Cite this